antibodies thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIb { alpha } Relative efficacy of intravenous immunoglobulin G in ameliorating
暂无分享,去创建一个
B. Nieswandt | Pingguo Chen | E. Sayeh | John | M. Crow
[1] Y. Ozaki,et al. Platelet GPIb‐IX‐V‐dependent signaling , 2005, Journal of thrombosis and haemostasis : JTH.
[2] T. Trujillo,et al. Intravenous Immunoglobulin–Associated Acute Renal Failure: Case Series and Literature Review , 2005, Pharmacotherapy.
[3] M. Jaloudi,et al. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature , 2004, Annals of Hematology.
[4] R. Mcmillan. Antiplatelet Antibodies in Chronic Adult Immune Thrombocytopenic Purpura: Assays and Epitopes , 2003, Journal of pediatric hematology/oncology.
[5] Shirley A. Williams,et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. , 2003, Blood.
[6] A. Lazarus,et al. Mechanism of action of IVIG and anti-D in ITP. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[7] A. Newland,et al. Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults , 2002, British journal of haematology.
[8] L. Tengborn,et al. Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function. , 2002, Thrombosis research.
[9] J. Freedman,et al. IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity , 2001, British journal of haematology.
[10] L. Roskos,et al. Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy , 2001, American journal of hematology.
[11] B. Nieswandt,et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. , 2000, Blood.
[12] J. Kelton,et al. Idiopathic immune thrombocytopenic purpura: an update. , 2000, Seminars in hematology.
[13] R. Mcmillan. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. , 2000, Seminars in hematology.
[14] M. Ertem,et al. Platelet autoantibodies in immune thrombocytopenic purpura. , 1998, Transfusion science.
[15] H. Hartung,et al. Intravenous immunoglobulin treatment of neurological autoimmune diseases , 1998, Journal of the Neurological Sciences.
[16] C. E. Jones,et al. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. , 1994, Blood.
[17] P. Bierling,et al. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. , 1993, Blood.
[18] L. Horstman,et al. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.
[19] S. Nomura,et al. Synergistic action in platelet activation induced by an antiplatelet autoantibody in ITP , 1991, British journal of haematology.
[20] R. Aster,et al. Identification of glycoprotein Ib as a target for autoantibody in idiopathic (autoimmune) thrombocytopenic purpura. , 1986, Blood.
[21] R. Montgomery,et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. , 1984, Blood.
[22] Virgil L. Woods,et al. PLATELET AUTOANTIGENS IN CHRONIC ITP , 1984, British journal of haematology.
[23] W. Harrington,et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. , 1951, The Journal of laboratory and clinical medicine.
[24] Y. Shoenfeld,et al. New therapeutic avenues in autoimmunity. , 1996, Research in immunology.
[25] E. Milner,et al. Sequence analysis of monoclonal antibodies derived from a patient with idiopathic thrombocytopenic purpura. , 1990, Autoimmunity.